Origin House Announces Record Quarterly Revenue of $11.2 Million for the First Quarter of 2019; Sequential Growth of 41% from Q4 2018

CNW Group - finance.yahoo.com Posted 4 years ago

Pro-Forma Q1 2019 Revenue including 180 Smoke for a full quarter would have been $13.1 million

OTTAWA , May 29, 2019 /CNW/ - CannaRoyalty Corp. d/b/a Origin House (OH.CN) (ORHOF) ("Origin House" or the "Company"), a North American cannabis products and brands company, today announced its financial results for the three months ended March 31, 2019 . All figures are reported in Canadian dollars ($), unless otherwise indicated. Origin House's financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").

As previously announced, the Company will hold a Special Meeting of shareholders on June 11, 2019 in connection with its previously announced statutory plan of arrangement pursuant to which Cresco Labs Inc. ("Cresco Labs") will acquire all of the issued and outstanding shares of Origin House (the "Arrangement").

Marc Lustig , CEO and Chairman of Origin House commented, "This was a milestone quarter for Origin House, as the team drove solid organic growth within our Californian distribution and brands platform and completed meaningful strategic merger and acquisition-based initiatives including the addition of 180 Smoke in Canada . Moving forward through the balance of the year, we are confident that, once completed, the combination of Cresco Labs' scale and Origin House's California -wide distribution footprint will further accelerate growth and build significant value for the shareholders of both companies."

Financial Highlights for the first quarter ended March 31, 2019

The following are financial highlights of Origin House's operating results for the three months ended March 31, 2019 , compared to the three months ended March 31, 2018 :

  • Revenue was $11.2 million as compared to $0.6 million ;
  • Gross margin was $1.7 million as compared to $nil;
  • Operating expenses were $18.2 million as compared to $4.5 million ; 
  • Adjusted EBITDA loss of $12.7 million as compared to adjusted EBIDTA loss of $0.9 million . 


The following is a summary of key balance sheet items as at March 31, 2019 , compared to December 31 , 2018: 

  • Cash was $39.3 million as compared to $69.2 million ;
  • Total assets of $269.4 million as compared to $230.7 million ;
  • Current assets of $68.7 million as compared to $86.0 million ;
  • Current liabilities of $34.2 million as compared to $26.2 million ; and
  • Long-term debt financing of $nil as compared to $16.0 million .


Pro-Forma Disclosure

If the 180 Smoke acquisition had occurred on January 1, 2019 , management estimates that for the three months ended March 31 , 2019:  

  • Pro-forma consolidated revenue would have been $13.1 million ; and
  • Pro-forma consolidated net loss would have been $17.7 million .


Corporate Highlights subsequent to the quarter ended March 31, 2019

For a more comprehensive overview of these recent developments, please refer to Origin House's Management Discussion and Analysis of the Financial Condition and Results of Operations for the Three Months ended March 31, 2019 .

  • On May 28, 2019 , Origin House subsidiary Trichome Financial ("Trichome") announced that 22 Capital Corp. and Trichome received conditional approval from the TSX Venture Exchange for their previously announced amalgamation under the provisions of the Business Corporations Act ( Ontario ) that will result in a reverse take-over of 22 Capital by the shareholders of Trichome (the "Transaction"). The closing of the Transaction is expected to take place on or around July 5, 2019 or such other date as 22 Capital and Trichome may agree, subject to a number of conditions.
  • On May 15, 2019 , Trichome entered into a $4.5 million trade finance facility and a $1.5 million mortgage loan with Blissco Holdings Ltd., a wholly owned subsidiary of Blissco Cannabis Corp. (CSE:BLIS), a licensed producer under the Cannabis Act and a Canadian Wellness cannabis brand based in British Columbia .
  • On May 14, 2019 , Origin House filed its management information circular, letter of transmittal and related proxy materials, pursuant to its statutory plan of arrangement with Cresco Labs.
  • On May 3, 2019 , the Company obtained an interim order from the Ontario Superior Court of Justice (Commercial List) in connection with its previously announced statutory plan of arrangement pursuant to which Cresco Labs will acquire all of the issued and outstanding shares of Origin House.
  • On May 2, 2019 , the Company closed the acquisition of Cub City LLC ("Cub City"), a licensed premium craft cannabis producer based in Sonoma County California .
  • On April 10, 2019 , FloraCal and Cub City received permit approvals from Sonoma County, California , to commence facility expansions.
  • On April 1, 2019 , the Company entered into a definitive agreement to be acquired by Cresco Labs for approximately $1.1 billion , creating a North American cannabis powerhouse.


Results of Operations (Summary)           

The following tables set forth consolidated statements of financial information for the three months ended March 31, 2019 and March 31, 2018 . For further information regarding the Company's financial results for these periods, please refer to the Company's Management's Discussion and Analysis for the periods ended March 31, 2019 and March 31, 2018 and the Company's Financial Statements for the periods ended March 31, 2019 and March 31, 2018 , published on Origin House's issuer profile on SEDAR at www.sedar.com and the Company's website at www.OriginHouse.com.


March  31
2019

December 31
2018

Change

Selected statement of financial position data




Cash and cash equivalents

$

39,252,543

$

69,206,193

$

(29,953,650)

Working capital 

34,424,203

59,810,772

(25,386,569)

Total investments (1)

20,581,294

21,741,531

(1,160,237)

Total assets

269,412,325

230,698,045

38,714,280

Long term and convertible debt

-

16,026,098

(16,026,098)

Shareholders' equity

199,588,739

172,972,132

26,616,607

Dividend per share

-

-

-

(1) This represents the sum of investments, royalty investments, and interests in equity method investees

 


Three months ended March 31



2019

2018

% change

Consolidated statements of comprehensive loss




Revenue

$

11,161,161

$

643,437

1635%

Gross margin, excluding fair value items

1,516,775

(29,630)

5219%

Gross margin, including fair value items

1,652,727

(29,630)

5678%

Operating expenses

18,230,434

4,480,014

307%

Loss from operations

(16,577,707)

(4,509,644)

268%

Net loss    

(17,434,280)

(4,654,473)

275%

Other comprehensive loss

(3,047,605)

545,605

(659%)

Total comprehensive loss

(20,481,885)

(4,108,868)

398%

Net loss attributable to owners of the Company

(17,136,306)

(4,629,003)

270%

Net loss per common share - basic & diluted

(0.25)

(0.10)

150%

Weighted average common shares - basic & diluted

68,579,886

45,075,695

52%

 

Revenue by Type





Three months ended March 31

% change


2019

2018

California Operations segment




Product sales

$

9,247,507

$

84,773

10809%

Interest income

23,628

-


Other Income

30,806

-


Canadian Operations segment




Product sales

1,554,015

-


Royalties

11,266

-


Corporate segment




Services

33,807

429,817

(92%)

Royalties

-

119,058

(100%)

Interest income

260,132

9,789

2557%

Total

$

11,161,161

$

643,437

1635%

 

Cost of Sales by Revenue Type





Three months ended March 31

% change


2019

2018


California Operations segment




Cost of product sales

$

8,767,894

$

75,673

11487%

Canadian Operations segment




Cost of product sales

850,709

-


Corporate segment




Cost of services

8,745

209,023

(96%)

Cost of royalties

17,038

388,371

(96%)

Total

$

9,644,386

$

673,067

1333%

 

Gross Profit by Revenue Type





Three months ended March 31

% change


2019

2018

California Operations segment




Products

$

479,613

$

9,100

5170%

Interest income

23,628

-


Other Income

30,806

-


Canadian Operations segment




Products

703,306

-


Royalties

11,266

-


Corporate segment




Services

25,062

220,794

(89%)

Royalties

(17,038)

(269,313)

94%

Interest

260,132

9,789

2557%

Gross margin, excluding fair value items

$

1,516,775

$

(29,630)

5219%

Realized fair value amounts of inventory sold

(971,143)

-


Unrealized fair value gain on biological assets

1,107,095

-


Gross margin

$

1,652,727

$

(29,630)

5678%

 

Gross Margin by Revenue Type


Three months ended March 31

% change


2019

2018

California Operations segment




Products

5%

11%

52%

Interest income

100%

-


Other Income

100%

-


Canadian Operations segment




Products

45%

-


Royalties

100%

-


Corporate segment




Services

74%

51%

44%

Royalties

-

(226%)

(100%)

Interest

100%

100%

-

Gross margin, excluding fair value items

14%

(5%)

(395%)

Effect of changes in fair value of biological assets on margin

1%

-


Gross margin

15%

(5%)

(422%)

 

Operating Expenses


Three months ended March 31



2019

2018

Change

Sales and marketing 

$

4,444,982

$

478,516

829%

Research and product development

786,225

75,965

935%

General and administrative

11,356,889

3,750,426

203%

Amortization of intangibles

1,642,338

175,107

838%

Total

$

18,230,434

$

4,480,014

307%

 

Non-IFRS Financial Measures
The Company has provided unaudited pro forma financial information, which assumes that closed mergers and acquisitions in 2019 are included in the Company's financial results as of the beginning of fiscal 2019. EBITDA and Adjusted EBITDA are non-IFRS measures and do not have standardized definitions under IFRS. The Company has provided the non-IFRS financial measures, which are not calculated or presented in accordance with IFRS, as supplemental information and in addition to the financial measures that are calculated and presented in accordance with IFRS. These supplemental non-IFRS financial measures are presented because management has evaluated the financial results both including and excluding the adjusted items and believe that the supplemental non-IFRS financial measures presented provide additional perspective and insights when analyzing the core operating performance of the business.

  • 1
  • 2